About Cardiovascular Clinical Trials
Cardiovascular diseases are a leading cause of morbidity and mortality. Long term inadequate control of blood pressures increases the risk of damage in multiple organs including heart, kidneys, brain and eyes. It is a major risk factor for long term complications such as heart attacks, strokes, arrhythmias, chronic kidney disease, etc.
To be contacted about this study, fill out the contact form or call 425-453-0404.
NWCRC is participating in a novel clinical trial evaluating an RNA-based therapy. This drug targets liver mRNA to inhibit the synthesis of a molecule (called angiotensinogen) that leads to hypertension.
By interrupting production of this molecule at source, it offers potential for more robust and sustained control of hypertension. This strategy holds promise not only for improved blood pressure management but also for meaningful reduction in cardiovascular risk, morbidity, and mortality.
Clinical Study Participation
Northwest Clinical Research Center is looking for adults age 18 and older who are on treatment for high blood pressure with inadequate control.
Duration
Up to 2.5 to 5 years
No Cost Study
There is no cost to participate in the study, and the study participant will receive the following:
- Medical evaluation
- Blood pressure monitoring
- Investigational Medication
- Study Related Medical Care
- Compensation available
- Complimentary transportation or a travel stipend if eligible
